These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 10806619)

  • 1. Detection of TGF-beta type II receptor hot-spot mutations: the BAT-RII assay.
    Myeroff LL; Markowitz S
    Methods Mol Biol; 2000; 142():133-7. PubMed ID: 10806619
    [No Abstract]   [Full Text] [Related]  

  • 2. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
    Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
    Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
    Grady WM; Myeroff LL; Swinler SE; Rajput A; Thiagalingam S; Lutterbaugh JD; Neumann A; Brattain MG; Chang J; Kim SJ; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
    Cancer Res; 1999 Jan; 59(2):320-4. PubMed ID: 9927040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.
    Lücke CD; Philpott A; Metcalfe JC; Thompson AM; Hughes-Davies L; Kemp PR; Hesketh R
    Cancer Res; 2001 Jan; 61(2):482-5. PubMed ID: 11212236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
    Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
    J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
    Biswas S; Trobridge P; Romero-Gallo J; Billheimer D; Myeroff LL; Willson JK; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2008 Feb; 47(2):95-106. PubMed ID: 17985359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
    J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines.
    Lee HJ; Chang JH; Kim YS; Kim SJ; Yang HK
    J Exp Clin Cancer Res; 2003 Sep; 22(3):477-80. PubMed ID: 14582709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M; Ihn H; Yamane K; Tamaki K
    Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.
    Hattori H; Matsuzaki A; Suminoe A; Ihara K; Nagatoshi Y; Sakata N; Kawa K; Okamura J; Hara T
    Bone Marrow Transplant; 2002 Nov; 30(10):665-71. PubMed ID: 12420205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta receptor II mRNA in cyclosporine-induced gingival overgrowth.
    Stefanidou V; Liakopoulos V; Eleftheriadis T; Anifandis G; Mertens PR; Kanelaki E; Stefanidis I
    Transplant Proc; 2006 Nov; 38(9):2905-8. PubMed ID: 17112860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencing.
    Myeroff LL; He H; Fink SP; Markowitz S
    Methods Mol Biol; 2000; 142():139-47. PubMed ID: 10806620
    [No Abstract]   [Full Text] [Related]  

  • 16. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
    Tanaka H; Yamaba H; Kosugi N; Mizutani H; Nakata S
    Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S57-64. PubMed ID: 18060420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH; Birchenall-Roberts MC; Yi Y; Lee BI; Lee DK; Bertolette DC; Fu T; Ruscetti F; Kim SJ
    Cell Growth Differ; 2001 Jan; 12(1):9-18. PubMed ID: 11205746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
    Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.